TipRanks
Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C
Germany Market
XE7C
Cardiff Oncology
RESEARCH TOOLSreports

Cardiff Oncology (XE7C) Income Statement

3 Followers

Cardiff Oncology Income Statement

Last quarter (Q2 2026), Cardiff Oncology's total revenue was $104.00K, a decrease of -14.05% from the same quarter last year. In Q2, Cardiff Oncology's net income was $-9.23M. See Cardiff Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Gross Profit
$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Operating Expenses
$ 49.55M$ 49.33M$ 45.90M$ 40.29M$ 29.21M
Depreciation and Amortization
$ 904.00K$ 404.00K$ 398.00K$ 236.00K$ 451.00K
EBITDA
$ -44.95M$ -45.03M$ -41.04M$ -38.47M$ -27.84M
Operating Income
$ -48.96M$ -48.65M$ -45.41M$ -39.90M$ -28.86M
Other Income/Expenses
$ 3.11M$ 3.22M$ 3.97M$ 1.20M$ 564.00K
Pretax Income
$ -45.85M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Net Income
$ -45.85M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Per Share Metrics
Basic EPS
$ -0.69$ -0.95$ -0.93$ -0.89$ -0.73
Diluted EPS
$ -0.69$ -0.95$ -0.93$ -0.89$ -0.73
Weighted Average Shares Outstanding
 66.84M 47.65M 44.68M 43.60M 39.03M
Weighted Average Shares Outstanding (Diluted)
 66.84M 47.65M 44.68M 43.60M 39.03M
Currency in USD

Cardiff Oncology Earnings and Revenue History